Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 16/20 | 0.53 |
| ▸ | CKS1B | P61024 | 2/20 | 0.41 |
| ▸ | SKP1 | P63208 | 2/20 | 0.41 |
| ▸ | SKP2 | Q13309 | 2/20 | 0.41 |
| ▸ | HPGDS | O60760 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2704945 | 0.77 | CNR1 (0.67) | CNR1 | |
| SCHEMBL5773432 | 0.77 | CNR1 (0.62) | CNR1 | |
| SCHEMBL4252468 | 0.76 | CNR1 (0.61) | CNR1 | |
| SCHEMBL4677223 | 0.76 | CNR1 (0.44) | CNR1 | |
| SCHEMBL5452416 | 0.74 | CNR1 (0.61) | CNR1 | |
| SCHEMBL12474883 | 0.74 | TRPA1 (0.57) | — | |
| SCHEMBL5771581 | 0.74 | CNR1 (0.63) | CNR1 | |
| SCHEMBL2702037 | 0.72 | KDM4E (0.48) | CNR1 | |
| SCHEMBL441931 | 0.72 | CNR1 (0.47) | CNR1 | |
| SCHEMBL4676483 | 0.72 | CNR1 (0.46) | CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060135523-A1 | 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | US | claimed |
| EP-1641779-A1 | 2-SUBSTITUED 5, 6-DIARYL-PYRAZINE DERIVATIVES AS CB1 MODULATOR. | AstraZeneca AB (SE) | 2006-04-05 | — | — | EP | claimed |
| WO-2004111033-A1 | 2-SUBSTITUED 5, 6-DIARYL-PYRAZINE DERIVATIVES AS CB1 MODULATOR. | ASTRAZENECA AB (SE) | 2004-12-23 | — | — | WO | claimed |
| EP-4307380-A1 | DISPLAY PANEL AND DISPLAY DEVICE | Huawei Technologies Co., Ltd. (CN) | 2024-01-17 | — | — | EP | disclosed |
| CN-107400394-B | A kind of pearlescent pigment and preparation method thereof being directly used in electrostatic powder coating | 福建坤彩材料科技股份有限公司 | 2019-10-15 | — | — | CN | disclosed |
| CN-107293593-B | Display panel and display device | 上海天马微电子有限公司 | 2019-09-24 | — | — | CN | disclosed |
| CN-110119217-A | The touch screen and terminal device of tin indium oxide film layer structure | 深圳莱宝高科技股份有限公司 | 2019-08-13 | — | — | CN | disclosed |
| CN-208954995-U | A kind of thin-film solar cells | 北京铂阳顶荣光伏科技有限公司 | 2019-06-07 | — | — | CN | disclosed |
| CN-109827918-A | The measuring method of silicone content in tin-doped indium oxide powder | 广西壮族自治区冶金产品质量检验站 | 2019-05-31 | — | — | CN | disclosed |
| CN-109827953-A | The measuring method of iron, aluminium, lead, nickel, copper, cadmium, chromium and thallium content in tin-doped indium oxide powder | 广西壮族自治区分析测试研究中心 | 2019-05-31 | — | — | CN | disclosed |
| CN-109813741-A | The method that material phase analysis is carried out to tin-doped indium oxide powder using X-ray diffraction method | 广西壮族自治区冶金产品质量检验站 | 2019-05-28 | — | — | CN | disclosed |
| CN-202601714-U | Combined electrode suitable for high-power GaN-based LED chip | SHIKETE PHOTOELECTRIC MATERIAL KUNSHAN CO LTD | 2012-12-12 | — | — | CN | disclosed |
| CN-102709431-A | Composition electrode applicable to large-power gallium nitride (GaN) based light-emitting diode (LED) chip | SHIKETE PHOTOELECTRIC MATERIAL KUNSHAN CO LTD | 2012-10-03 | — | — | CN | disclosed |
| CN-102480006-A | Transparent metamaterial | SHENZHEN KUANG CHI INST | 2012-05-30 | — | — | CN | disclosed |
| CN-102265411-A | Light receiving element, light receiving element array, method for manufacturing light receiving element, and method for manufacturing light receiving element array | — | 2011-11-30 | — | — | CN | disclosed |
| WO-2006071586-A1 | BORON COMPOUNDS AS STABILIZERS IN PHOTOTHERMOGRAPHIC MATERIALS | CARESTREAM HEALTH, INC. (US) | 2006-07-06 | — | — | WO | disclosed |
| US-20060135523-A1 | 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | US | disclosed |
| EP-1641779-A1 | 2-SUBSTITUED 5, 6-DIARYL-PYRAZINE DERIVATIVES AS CB1 MODULATOR. | AstraZeneca AB (SE) | 2006-04-05 | — | — | EP | disclosed |
| WO-2006028849-A1 | DEVELOPER DISPERSIONS FOR THERMALLY DEVELOPABLE MATERIALS | EASTMAN KODAK COMPANY (US) | 2006-03-16 | — | — | WO | disclosed |
| WO-2004111033-A1 | 2-SUBSTITUED 5, 6-DIARYL-PYRAZINE DERIVATIVES AS CB1 MODULATOR. | ASTRAZENECA AB (SE) | 2004-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135523-A1 | 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator | CNR2, CNR1, GPR55 | CNR1 2/4885CKS1B 1482/4885SKP1 2266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.